CTAG2 anticorps (AA 140-190) (Cy5)
-
- Antigène Voir toutes CTAG2 Anticorps
- CTAG2 (Cancer/testis Antigen 2 (CTAG2))
-
Épitope
- AA 140-190
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CTAG2 est conjugé à/à la Cy5
-
Application
- Western Blotting (WB)
- Réactivité croisée
- Humain
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human CTAG2
- Isotype
- IgG
- Top Product
- Discover our top product CTAG2 Anticorps primaire
-
-
- Indications d'application
- IF(IHC-P) 1:50-200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- CTAG2 (Cancer/testis Antigen 2 (CTAG2))
- Autre désignation
- Ctag2 (CTAG2 Produits)
- Synonymes
- anticorps CAMEL, anticorps CT2, anticorps CT6.2, anticorps CT6.2a, anticorps CT6.2b, anticorps ESO2, anticorps LAGE-1, anticorps LAGE2B, anticorps cancer/testis antigen 2, anticorps CTAG2
- Sujet
-
Synonyms: CT2, ESO2, CAMEL, CT6.2, CT6.2a, CT6.2b, LAGE-1, LAGE2B, Cancer/testis antigen 2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 6.2, L antigen family member 1, CTAG2, LAGE1
Background: Testis and very low level in placenta and in some uterus samples. Observed in 25-50 % of tumor samples of melanomas, non-small-cell lung carcinomas, bladder, prostate and head and neck cancers.
- ID gène
- 30848
- UniProt
- O75638
-